These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37401098)

  • 1. Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?
    Vieujean S; Kotze PG; Netter P; Germain A; Louis E; Danese S; Peyrin-Biroulet L
    Expert Opin Pharmacother; 2023; 24(14):1595-1607. PubMed ID: 37401098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
    Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY;
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study.
    Agrawal M; Ebert AC; Poulsen G; Ungaro RC; Faye AS; Jess T; Colombel JF; Allin KH
    Gastroenterology; 2023 Oct; 165(4):976-985.e3. PubMed ID: 37321356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
    Ponsioen CY; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Bossuyt PMM; Hart A; Warusavitarne J; Buskens CJ; van Bodegraven AA; Brink MA; Consten ECJ; van Wagensveld BA; Rijk MCM; Crolla RMPH; Noomen CG; Houdijk APJ; Mallant RC; Boom M; Marsman WA; Stockmann HB; Mol B; de Groof AJ; Stokkers PC; D'Haens GR; Bemelman WA;
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):785-792. PubMed ID: 28838644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of ileocecal Crohn's disease in the current era.
    Yamamoto T; Lightner AL; Spinelli A; Kotze PG
    Expert Rev Gastroenterol Hepatol; 2020 Sep; 14(9):843-855. PubMed ID: 32729736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after ileocecal resection for Crohn's disease.
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH
    Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-making in ileocecal Crohn's disease management: surgery versus pharmacotherapy.
    Eshuis EJ; Stokkers PC; Bemelman WA
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):181-9. PubMed ID: 20350265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive ileocecal valve resection in ileocecal Crohn's disease.
    Benassai G; Serra C; Romeo G; Calemma F; Maione F; Portinaio M; Scevola M; Benassai G; Quarto G
    Ann Ital Chir; 2022; 93():680-688. PubMed ID: 36617283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
    Rosenfeld G; Qian H; Bressler B
    J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis.
    Diederen K; de Ridder L; van Rheenen P; Wolters VM; Mearin ML; Damen GM; de Meij TG; van Wering H; Tseng LA; Oomen MW; de Jong JR; Sloots CE; Benninga MA; Kindermann A
    Inflamm Bowel Dis; 2017 Feb; 23(2):272-282. PubMed ID: 28079626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of laparoscopic ileocecal resection for Crohn's disease before the era of biologics.
    Rink AD; Fischer IR; Vestweber B; Vestweber KH
    Int J Colorectal Dis; 2014 Jan; 29(1):127-32. PubMed ID: 23857597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
    Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhood.
    Diederen K; de Ridder L; van Rheenen P; Wolters VM; Mearin ML; de Meij TG; van Wering H; Oomen MW; de Jong JR; Sloots CE; Benninga MA; Kindermann A
    Eur J Pediatr; 2019 Sep; 178(9):1413-1421. PubMed ID: 31327075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).
    Eshuis EJ; Bemelman WA; van Bodegraven AA; Sprangers MA; Bossuyt PM; van Milligen de Wit AW; Crolla RM; Cahen DL; Oostenbrug LE; Sosef MN; Voorburg AM; Davids PH; van der Woude CJ; Lange J; Mallant RC; Boom MJ; Lieverse RJ; van der Zaag ES; Houben MH; Vecht J; Pierik RE; van Ditzhuijsen TJ; Prins HA; Marsman WA; Stockmann HB; Brink MA; Consten EC; van der Werf SD; Marinelli AW; Jansen JM; Gerhards MF; Bolwerk CJ; Stassen LP; Spanier BW; Bilgen EJ; van Berkel AM; Cense HA; van Heukelem HA; van de Laar A; Slot WB; Eijsbouts QA; van Ooteghem NA; van Wagensveld B; van den Brande JM; van Geloven AA; Bruin KF; Maring JK; Oldenburg B; van Hillegersberg R; de Jong DJ; Bleichrodt R; van der Peet DL; Dekkers PE; Goei TH; Stokkers PC
    BMC Surg; 2008 Aug; 8():15. PubMed ID: 18721465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
    Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
    Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
    Arkenbosch JHC; Mak JWY; Ho JCL; Beelen EMJ; Erler NS; Hoentjen F; Bodelier AGL; Dijkstra G; Romberg-Camps M; de Boer NKH; Stassen LPS; van der Meulen AE; West R; van Ruler O; van der Woude CJ; Ng SC; de Vries AC
    Inflamm Bowel Dis; 2022 Jun; 28(Suppl 2):S16-S24. PubMed ID: 34969091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
    Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B
    Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
    Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
    Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.